PSA unveils HDP program
August 3, 2015
The Pharmaceutical Society of
Australia has formally launched its
new Health Destination Pharmacy
(HDP) Program, described by
national president Joe Demarte as
a “financially viable and sustainable
change platform for pharmacies”.
Unveiled during the PSA15
conference in Sydney yesterday,
HDP aims to help pharmacies
transition from reliance on a
“price-focused, discount model to a
consumer-focused model.
“It is a program that is evidence
based, allowing pharmacies to
experience high levels of patient
loyalty, pharmacists’ satisfaction
and financial sustainability less
reliant on government funding,”
Demarte said.
The program uses an intense
coaching model targeting business
and financial planning, people and
processes, marketing, layout and
infrastructure.
HDP involves an “unprecedented”
partnership between PSA and a
range of industry stakeholders,
with an advisory group including
representatives of Pfizer, Bayer,
Reckitt Benckiser, J&J, Blackmores,
Willach, NAB Health and Danone
Nutricia, along with UTS Sydney’s
Professor Charlie Benrimoj, Bruce
Annabel from JR Pharmacy Services
& Glenn Guilfoyle of The Next Level.
Demarte said HDP was “a key
strategy of the PSA vision for
excellence in pharmacist care”.
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Aug 15To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Aug 15
